DNA tests for tumours can be a game-changer
Patient story: A cutting-edge DNA test put Inke Logtenberg on the right treatment path. Now she hopes others with Cancer of Unknown Primary (CUP) will have swift access to personalized care Inke knew something wasn’t right. She had some swelling in a lymph node in her groin, prompting a trip to the doctor. After a […]
A personal plea for personalized medicine
Warnyta Minnaard lost her partner, Hederik, to Cancer of Unknown Primary (CUP). Heartbreak inspired her to spearhead a campaign for the reimbursement of whole genome sequencing in the Netherlands so that others might be spared the same fate Hederik was just 32 when he became ill three years ago. It began with a drooping eyelid […]
Could genetic testing unlock treatments for Cancer of Unknown Primary?
World CUP Week: Researchers are screening hundreds of tumour genes in search of drug targets that could open the door to more personalised cancer care Most cancers are named – and treated – according to where the first tumour is found. But for some patients, tumours are detected in various organs of the body but […]
Raising awareness of Cancers of Unknown Primary
CUP Awareness Week: connecting researchers, clinicians and patient advocates Cancer is usually diagnosed and treated based on where it began. If the disease originates in the lung, it is called lung cancer even if it spreads to the bones or the liver. This matters because it informs treatment decisions, prompting oncologists to follow standard pathways […]
“We’re at a critical moment for precision medicine in cancer care”
Cancer will only be beaten when the genomic drivers of a person’s cancer are understood and targeted, according to Brian Tomlinson of Foundation Medicine Tell me about yourself and your organization Foundation Medicine is a molecular information company dedicated to transforming cancer care through a deep understanding of the genomic changes that contribute to each […]
‘I am on a mission to fix that’
Susan McClure, founder and CEO of Genome Creative, says that while clinical adoption of targeted treatments remains low, multi-stakeholder efforts such as FT3 can change this Tell us more about your organization We specialize in content strategy, editorial and design updates, event creation and management, websites, podcasts, apps, and marketing. Specifically, we work with partners […]
‘True personalized medicine should be the goal’
Dr Benedikt Westphalen is a medical oncologist and molecular biologist, focusing on gastrointestinal oncology and precision oncology. For the last four years, he has been building a precision oncology program at the University of Munich.
‘This is a unique collaboration’
Tanya Knott, Director, SJK Foundation, spoke to Danielle Barron about her vision of personalized medicine and the personal tragedy that drives her to make it a reality. Tell us more about you I am the founder and director of the Sarah Jennifer Knott Foundation. I established the foundation with family and friends in 2016 following […]
‘No two people are the same’
President of Lung Cancer Europe and molecular biologist, Dr. Anne-Marie Baird says personalized medicine should mean the best medicine, care, and support for people on an individualized basis Tell us more about yourself? I am a molecular biologist and have worked extensively on mesothelioma and lung cancer, with research interests in inflammation, the metastatic cascade, […]